Effects of pentoxifylline and metformin combination therapy compared to metformin alone in infertile women with symptomatic endometrioma

Endometriosis, a chronic inflammatory disease, significantly affects reproductive health and fertility in women. This study compares the efficacy of pentoxifylline plus metformin versus metformin alone in treating symptomatic endometrioma in infertile women.

This randomized controlled trial was conducted at the department of reproductive endocrinology and infertility, BSMMU, Dhaka, from July 2022 to June 2023, involving 51 women. Participants were randomly allocated into two groups: pentoxifylline plus metformin (n=25) and metformin alone (n=26). Baseline and post-treatment evaluations included the size of endometrioma, pain scores using the visual analogue scale (VAS), and serum interleukin-6 (IL-6) levels. Data analysis focused on comparing treatment outcomes between the two groups.

At baseline, both groups were comparable in terms of sociodemographic characteristics, BMI, and type and duration of infertility. Post-treatment, the pentoxifylline plus metformin group showed significant reductions in endometrioma size (2.23±0.97 cm), VAS score (2.73±1.21), and IL-6 levels, all with p<0.001s. In contrast, the metformin alone group exhibited a significant reduction in endometrioma size (3.12±1.42 cm, p=0.003s) and VAS score (3.48±1.89, p<0.001s), but not in IL-6 levels (p=0.505ns). Pregnancy rates were 8.0% in the pentoxifylline plus metformin group and 3.85% in the metformin alone group (p=0.610ns). Side effects were minimal and comparable between the two groups.

Pentoxifylline plus metformin demonstrated superior efficacy in reducing endometrioma size, pain scores, and IL-6 levels compared to metformin alone. However, no significant differences were observed in pregnancy rates or side effects. These findings indicate that the combination therapy could offer greater benefits in managing endometrioma size and pain, although further research is required to evaluate its impact on fertility outcomes in endometriosis patients. Metrics

Khine YM, Taniguchi F, Harada T. Clinical management of endometriosis-associated infertility. Reprod Med Biol. 2016;15(4):217-25. Hamid AMSA, Madkour WAI, Moawad A, Elzaher MA, Roberts MP. Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study. Arch Gynecol Obstet. 2014;290(4):677-82. Park A, Chang P, Ferin M, Xiao E, Zeitoun K. Inhibition of endometriosis development in rhesus monkeys by blocking VEGF receptor: A novel treatment for endometriosis. Fertil Steril. 2004;82:S71. Alborzi S, Ghotbi S, Parsanezhad ME, Dehbashi S, Alborzi S, Alborzi M. Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study. J Minim Invasive Gynecol. 2007;14(1):54-8. Ferrero S, Ragni N, Remorgida V. Antiangiogenic therapies in endometriosis. Br J Pharmacol. 2006;149(2):133-5. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril. 2001;75(1):1-10. Akoum A, Lemay A, Paradis I, Rheault N, Maheux R. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum Reprod. 1996;11(10):2269-75. Velazquez EM, Mendoza SG, Wang P, Glueck CJ. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism. 1997;46(4):454-7. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vanderkerchove P. Ovulation suppression for endometriosis for women with subfertility. Cochrane Database Systematic Rev. 2007;(3). Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, et al. An update on the pharmacological management of endometriosis. Expert Opinion Pharmacotherapy. 2013;14(3):291-305. Gleicher N. Immune dysfunction-a potential target for treatment in endometriosis. Int J Obstetr Gynaecol. 1995;102(s12):4-7. Bruun JM, Pedersen SB, Richelsen B. Interleukin-8 Production in Human Adipose Tissue. Inhibitory Effects of Anti-Diabetic Compounds, the Thiazolidinedione Ciglitazone and the Biguanide Metformin. Horm Metab Res. 2000;32(11/12):537-41. Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y, et al. Metformin Suppresses Interleukin (IL)-1β-Induced IL-8 Production, Aromatase Activation, and Proliferation of Endometriotic Stromal Cells. J Clin Endocrinol Metabol. 2007;92(8):3213-8. Foda AA, Aal IAA. Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile. Middle East Fertil Society J. 2012;17(4):262-7. Yilmaz B, Sucak A, Kilic S, Aksakal O, Aksoy Y, Lortlar N, et al. Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. Am J Obstetr Gynecol. 2010;202(4):368.e1-8. Steinleitner A, Lambert H, Roy S. Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: a paradigm for a novel approach to the treatment of endometriosis-associated subfertility. Fertil Steril. 1991;55(1):26-31. Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Practice Res Clin Obstetr Gynaecol. 2004;18(2):319-28. Nothnick WB, Curry TE, Vernon MW. Immunomodulation of Rat Endometriotic Implant Growth and Protein Production. Am J Reproduct Immunol. 1994;31(2-3):151-62. Steinleitner A, Lambert H, Suarez M, Serpa N, Roy S. Immunomodulation in the treatment of endometriosis-associated subfertility: use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis a rodent model. Fertil Steril. 1991;56(5):975-9. Devi TR, Kadalmani B, Devi CA. Epidemiology of Endometriosis in Tamil Nadu, India. Asian Pacific J Health Sci. 2022;9(3):15-24. Ajayi AB, Afolabi BM, Ajayi VD, Oyetunji I, Saanu O, Atiba A, et al. Menstrual Characteristics of sub-Sahara Black African Women with and without Endometriosis. West Afr J Med. 2021;38(3):246-54. Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstetr Gynecol. 2007;196(4):402.e1-11. Creus M, Fábregues F, Carmona F, Del Pino M, Manau D, Balasch J. Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial. Human Reproduct. 2008;23(8):1910-6. Rani C, Deeba F, Ishrat S, Banu J, Jahan S, Nazneen S, et al. Effects of metformin plus myo-inositol compared to metformin alone as pre-treatment of ovulation induction in polycystic ovary syndrome with insulin resistance. Int J Reproduct Contracept Obstetr Gynecol. 2022;11(11):3005-11. Taniguchi F, Enatsu A, Ota I, Toda T, Arata K, Harada T. Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma. Eur J Obstetr Gynecol Reproduct Biol. 2015;191:116-20. Grammatis A, Georgiou EX, Becker CM. O-134 Cochrane review on the effect of pentoxifylline for endometriosis. Human Reproduct. 2021;36(1):deab126.059. Balasch J, Creus M, Fábregues F, Carmona F, Martínez-Román S, Manau D, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Human Reproduct. 1997 Sep 1;12(9):2046-50. Gardezi SFZ, Mahmood S, Ahmad A. Role of endometriosis as a risk factor for the females with primary sub-fertility. J Med Physiol Biophys. 2019;55(0):49. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27(8):4417. Eisenberg VH, Decter DH, Chodick G, Shalev V, Weil C. Burden of Endometriosis: Infertility, Comorbidities, and Healthcare Resource Utilization. J Clin Med. 2022;11(4):1133.